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Background: Microbial metabolites are of great importance to the pharmaceutical industries. There is 
an urgent need of novel microbial metabolites in the present scenario to combat antimicrobial 
resistance. Selection and screening of potent microbial strains for production of antimicrobial 
metabolites as well as optimization of their culture conditions is of utmost importance in drug 
discovery. Therefore, the study was carried out to evaluate the effect of nutritional and cultural 
conditions on the production of bioactive metabolites by a rare tea garden actinobacterial strain 
Amycolatopsis sp. ST-28.  
Materials and methods: Submerged fermentation of the actinobacterial isolate was carried out on 
different culture media and different culture conditions such as carbon and nitrogen sources, inoculum 
volume, pH, fermentation period and agitation speed. The culture filtrate was assayed against 
Staphylococcus aureus. Agar well diffusion method was employed to determine the maximum 
diameter of zone of inhibition (mm). The dried mycelial weight (mg) in a fixed volume of culture 
media was used for the determination of the total biomass produced. 
Results: Maximum bioactive metabolite and biomass production was observed when submerged 
fermentation was carried out with mannose and peptone respectively as a sole carbon and nitrogen 
source. Maintaining other environmental parameters viz. inoculum 11% (v/v), pH of 6.5, temperature 
of 32ºC and incubation period of 11 days at 150 rpm were found optimum for maximum antimicrobial 
activity.                                       
Conclusion: This study demonstrated optimized cultural conditions for improved production of 
antimicrobial compound by Amycolatopsis sp. ST-28 
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Contexte: Les métabolites microbiens revêtent une grande importance pour les industries 
pharmaceutiques. Il existe un besoin urgent de nouveaux métabolites microbiens dans le scénario 
actuel pour lutter contre la résistance aux antimicrobiens. La sélection et le criblage de souches 
microbiennes puissantes pour la production de métabolites antimicrobiens, ainsi que l'optimisation de 
leurs conditions de culture, revêtent une importance capitale pour la découverte de médicaments. Par 
conséquent, l’étude a été réalisée pour évaluer l’effet des conditions nutritionnelles et culturelles sur la 
production de métabolites bioactifs par une rare souche d’actinobactéries de jardin de thé, 
Amycolatopsis sp. ST-28. 
Matériels et méthodes: La fermentation immergée de l'isolat actinobactérien a été réalisée sur 
différents milieux de culture et différentes conditions de culture tels que les sources de carbone et 
d'azote, le volume d'inoculum, le pH, la période de fermentation et la vitesse d'agitation. Le filtrat de 
culture a été testé contre Staphylococcus aureus. La méthode de diffusion sur puits d’agar a été 
utilisée pour déterminer le diamètre maximum de la zone d’inhibition (mm). Le poids du mycélium 
séché (mg) dans un volume fixe de milieu de culture a été utilisé pour la détermination de la biomasse 
totale produite. 
Résultats: Une production maximale de métabolites bioactifs et de biomasse a été observée lors de la 
fermentation en immersion avec du mannose et de la peptone, respectivement, comme seule source 
de carbone et d'azote. Maintenir d'autres paramètres environnementaux à savoir. inoculum 11% (v / 
v), pH de 6,5, température de 32 ° C et période d’incubation de 11 jours à 150 tr / min ont été jugés 
optimaux pour une activité antimicrobienne maximale.        
Conclusion: Cette étude a démontré des conditions de culture optimisées pour une production 
améliorée de composé antimicrobien par Amycolatopsis sp. ST-28 
Mots clés: Amycolatopsis, antimicrobien, fermentation en immersion, optimisation 
Introduction: 
 Natural products with industrial 
applications are produced by the 
metabolism of living organisms (plants, 
animals or microorganisms). The most 
economical natural compounds produced 
by microorganisms, other than enzymes 
and recombinant proteins, are the low 
molecular weight primary and secondary 
metabolites (1). One microbe usually 
produces more than one compound, for 
example, a gentamicin-producing strain of 
Micromonospora produces 50 isolatable 
secondary metabolites (2).  
 Microbes isolated from nature 
usually produce extremely low levels of 
such metabolites. In order for a natural 
product to become a commercial reality, 
overproduction must be achieved initially 
at the laboratory level. Screening of 
proper strain and knowledge of microbial 
physiology is crucial to achieving higher 
metabolite production. The nutrition, 
growth and death rates, transport, 
energy, building blocks, polymer 
synthesis, regulation of enzyme synthesis, 
action and degradation, as well as   
cellular differentiation are some of the 
factors influencing natural metabolite 
production.    
 Production of antibiotics by 
microorganisms differs qualitatively and 
quantitatively depending on the strains 
and species of microorganisms used as 
well as on their nutritional and cultural 
conditions (3). Changes in the culture 
medium and the sole source of carbon and 
nitrogen have great influence on the 
growth and antibiotic production by 
microorganisms as reported by different 
researchers (4, 5, 6). Thus, a mastery of 
the fermentation process for each new 
strain, sound engineering knowledge of 
media optimization, and the fine-tuning of 
process conditions are required to yield 
integrated and successful processes (7). 
 Microbial products have so long 
been exploited for their richness in the 
medical field. There has been tremendous 
progress made and success recorded in 
the field of antibiotic since the discovery 
of penicillin. However, the war against 
infectious diseases is yet to be won 
because of ever increasing threats of 
antimicrobial resistance of the 
microorganisms. One of such threats is 




Staphylococcus aureus, an important 
pathogen of public health concern that has 
evolved into multiple antimicrobial 
resistant strains now considered a major 
problem. The organism can cause a wide 
variety of diseases ranging from 
superficial infections to severe life-
threatening diseases such as pneumonia, 
endocarditis, septicaemia, and variety of 
toxin-mediated diseases including 
staphylococcal scalded-skin syndrome and 
toxic shock syndrome (8, 9, 10).  
 The search for new antibiotics 
should therefore be continued in order to 
overcome resistance of microorganisms. 
In this respect, efforts are being made to 
exploit the chemical diversity of the rare 
actinobacteria isolated from unexplored 
habitats, which may increase the chances 
of discovering novel structures of 
biotechnological importance (11). One 
such possible candidate of this rare 
actinobacterial group is the genus 
Amycolatopsis, proposed by Lechevalier et 
al., in 1986 on the basis of 16S rRNA gene 
sequence analysis (12). Amycolatopsis 
belongs to family Pseudonocardiaceae 
(13, 14) which are Gram positive, non 
acid fast, non motile, catalase positive 
actinobacteria. There has been intense 
scientific interest and focus on this genus 
due to its ability to produce diverse group 
of antibiotics and secondary metabolites. 
Some important antibiotics such as 
balhimycin, dethymicin, rifamycin and 
vancomycin are produced by 
Amycolatopsis strains. There is therefore 
the need to conduct more elaborate 
studies on this prolific group of rare 
actinobacteria for better understanding of 
its hidden potential and diversity (15-18). 
 Northeast India has been identified 
as the Indo-Burma hotspot due to its rich 
variation in the flora and fauna (19). 
However, information about the microbial 
diversity of this region is sparse in the 
literature. Owing to its pristine location, it 
is a treasure house of diverse 
microorganisms and novel metabolites 
that is waiting to be discovered for 
medical use. In our course of investigation 
for novel microbial metabolites that have 
both pharmaceutical and agricultural 
importance, Amycolatopsis sp. ST-28, a 
tea garden isolate was screened against 
Staphylococcus aureus. In this study, 
attempt was made to determine the 
influence of different culture media, 
various carbon and nitrogen sources, 
inoculum volume, temperature, pH, 
aeration, and incubation period on invitro 
optimum growth and bioactive metabolite 
production by Amycolatopsis sp. ST-28. 
 
Materials and methods: 
 
Microbial strains 
 Amycolatopsis sp. ST-28 was 
isolated using various selective isolation 
procedures (20, 21) from tea garden              
soil in Golaghat district, Assam,                      
India (N 26027.534', E 093055.859'). 
Identification and characterization of the 
actinobacterial strain was done on the 
basis of colony morphology, biochemical 
and physiological properties (22, 23). The 
identity of the isolate was confirmed by 
PCR based 16S rRNA gene sequence 
analysis and the isolate has been 
deposited in GenBank with accession 
number (KY111723) (24). The strain was 
maintained in ISP-2 medium (yeast and 
malt extract medium) composed of yeast 
extract 4.0g, malt extract 10g, dextrose 
4g, agar 15g and pH 7.3. The test 
organism, Staphylococcus aureus MTCC-
737 was collected from the Institute                    
of Microbial Technology (IMTECH), 
Chandigarh, India. The organism was 
maintained on Mueller Hinton agar 
(HiMedia, India) and preserved at 4ºC for 
two months and in deep freezer at -70ºC 






 Two different media were used for 
production of inoculum with the following 
composition (g/L) (26); (i) IM-1 (Organic 
medium) composed of beef extract 3.0g, 
tryptone 5.0g, dextrose 1.0g, potato 
starch 24.0g, CaCo3 2.0g, and (ii) IM-2 
(Complex medium) composed of soyabean 
meal 10.0g, corn steep solid 10.0g, 




glucose 5.0g and CaCO3 5.0g. The 
colonies from the previously grown pure 
culture of Amycolatopsis sp. ST-28 in           
ISP-2 medium was scrapped with 5ml               
of distilled water to make a colony sus- 
pension (26). This was then transferred to 
45ml of each medium contained in 250ml 
capacity conical flasks which were 
incubated on a rotary shaking incubator at 
28±1ºC and 220 rpm for 48 hours. A 10% 
(v/v) inoculum was transferred to a 
production medium (composed of sucrose 
2.0g, malt extract 10g, yeast extract 
4.0g, dipotassium hydrogen phosphate 
5.0g, sodium chloride 2.5g, zinc sulphate 
0.04g, calcium carbonate 0.4g, 1.0L 
distilled water, and pH 7.0). The 
fermentation was run at 30ºC for 5 days 
on a rotary shaker at 220 rpm. The 
growth and antimicrobial activity were 
determined at the end of incubation 
period, and the best inoculum medium 
was used for optimization studies (26). 
 
Basal media preparation 
 Seven fermentation media 
(HiMedia Laboratories, Mumbai, India) 
were inoculated with the Amycolatopsis 
sp. ST-28 strain for the production of 
antimicrobial secondary metabolites 
containing the following compositions 
(g/L) at pH of 7; (i) Starch casein medium 
(SCM) with soluble starch 10.0g, casein 
1.0g, CaCO3.2H20 10.0g and K2HPO4 0.5g 
(22); (ii) Bennett’s medium (BM) with D-
glucose 10.0g, beef extract 1.0g, yeast 
extract 1.0g and N-Z amine type A (casein 
hydrolysate) 2.0g (27); (iii) Soyabean 
medium (SM) with Dextrin 15.0g, 
soyabean 30.0g, CaCO3.2H20 10.0g and 
MgSO4.7H20 1.0g (28); (iv) C medium 
(CM) with D-glucose 10.0g, soluble starch 
35.0g, casein hydolysates 5.0g, yeast 
extract 8.0g, meat extract 3.5g, soyabean 
meal 3.5g and CaCO3.2H2O 2.0g (29); (v) 
ISP-2 medium with glucose 4.0g, malt 
extract 10.0g and yeast extract 4.0g (30); 
(vi) ISP-4 medium with soluble starch 
10.0g, K2HPO4 1.0g, MGSO4.7H2O 1.0g, 
NaCl 1.0, (NH4)2SO4 2.0g, CaCO3 2.0g 
(22); and (vii) Glycerol asparagine 
medium (GAM) with L-asparagine 1.0g, 
glycerol 10.0g, K2HPO4 1.0g, and trace 
salt solution 1.0 ml (22).   
 The colony suspension of 
Amycolatopsis sp. ST-28 was prepared as 
described earlier. A 10% (v/v) inoculum 
was transferred to each of the above 
seven media and incubated at 30±1ºC for 
10 days on a rotary shaking incubator at 
220rpm. Growth and antimicrobial activity 
were determined at the end of incubation 
period and the best medium was selected 
as the basal medium which also serves as 
control for further experiments. 
 
Invitro antibiosis and microbial growth 
 The culture broth of Amycolatopsis 
sp. ST-28 was centrifuged and filter 
sterilized (with 0.4 m cellulose acetate). 
This was then bio-assayed against 
Staphylococcus aureus using agar well 
diffusion technique (31). Briefly, 0.1 ml of 
test bacterial suspension containing 3x108 
cells/ml was spread aseptically on Mueller 
Hinton agar and 50µL of culture broth was 
pipetted onto agar wells prepared by a 
sterile cork borer (6.00 mm in diameter). 
The diameter of zone of inhibition was 
recorded after 24 hours of incubation at 
30±2ºC. Growth was measured in terms 
of dry mycelial weight in a fixed volume 
(50 ml) of culture medium after drying the 
cell in an oven at 70ºC overnight (25). 
 
Optimization studies 
 Optimization of antimicrobial 
metabolite production was carried out with 
the removal and supplementation of 
nutrients based on single-dimension 
optimization (32). To determine the ideal 
condition for growth and maximum 
bioactive metabolite production, starch 
casein medium (SCM) with or without 
carbon and nitrogen sources was selected 
as the basal medium. A 10% (v/v) 
inoculum was transferred to the basal 
medium of 50ml. Flasks were incubated 
under stationary condition at 30±1ºC for 
10 days.  
 Various parameters influencing the 
growth and antimicrobial metabolite 
production viz effect of medium 
supplements such as carbon and nitrogen 
sources and effect of the physiological 
conditions such as pH, temperature, 




incubation period, inoculum size and 
agitation were studied. The experiments 
were conducted in triplicates. 
 
Carbon and nitrogen supplement 
 Lactose, glucose, mannose, 
glycerol, galactose, starch, mannitol, 
starch, ethanol, succinic acid and sucrose 
were used as carbon source, while sodium 
nitrate, potassium nitrate, ammonium 
sulphate, L-asparagine, peptone, beef 
extract, ammonium chloride, malt extract, 
yeast extract and L-tryptophan were used 
as nitrogen source. Each carbon and 
nitrogen source was incorporated 
separately at 1.0% (w/v) level into the 
basal medium. The carbon sources were 
ether-sterilized to prevent denaturation 
(22). 
 
Effect of temperature, pH, agitation, 
incubation period and inoculum volume 
 The optimum temperature for 
antimicrobial metabolite production was 
determined using different incubation 
temperatures ranging from 20 to 45±1°C 
in accordance with the method described 
by Suetsuna and Osajima in 1990 (33). 
Different pH values ranging from 5 to 9 
were used after adjusting pH level of the 
basal medium with 1N HCl or NaOH. To 
determine the effect of aeration on growth 
and active metabolite production, culture 
flasks were incubated at 32±1°C in an 
orbital shaking incubator at 150rpm as 
well as at stationary phase. The effect of 
incubation period for maximum growth 
and antimicrobial metabolite production 
was observed up to 20 days of incubation. 
For all the previous experiments, 10% 
(v/v) fresh culture was used as inoculum 
but in the present experiment, varying 
inoculum volumes of 2 to 15% (v/v) were 
evaluated. Fermentation was carried out 
and bioactive metabolite produced was 
assayed (26). 
 
Statistical analysis  
 The mean and standard errors of 
mean (±SE) were calculated for each 
experiment. Differences observed between 
various tested variables were determined 
using Analysis of Variance (ANOVA) and 
Fisher’s LSD was calculated with 
Statistical Package for the Social Sciences 
(SPSS) software version 18.0. Significance 
was considered where calculated p value 
was less than 0.05. 
Results: 
Choice of target organism 
 Amycolatopsis sp. ST-28 was 
assessed for its antimicrobial activity 
against Staphylococcus aureus and it 
showed prominent antimicrobial activity 
with zone of inhibition of 25±0.1 mm, 
hence for the study, it was taken as the 
choice target organism for culture filtrate 
assay. 
 
Standardization of inoculum and basal 
media 
 Two different media were tested 
for inoculum production, IM-1 and IM-2. 
IM-1 (Organic medium) produced growth 
with dry mycelial weight of 42±0.3 
mg/250ml and antimicrobial activity with 
diameter of inhibition of 9±0.1mm while 
IM-2 (Complex medium) produced growth 
with dry mycelial weight of 67±0.02 
mg/250 ml and antimicrobial activity with 
diameter of inhibition of 14 ±0.66 mm. 
Therefore IM-2, which supported 
maximum yield in terms of growth and 
antimicrobial activity, was used for further 
experiment.  
 Amycolatopsis sp. ST-28 produced 
highest biomass (65.33±1.2 mg) as well 
as bioactive metabolite with maximum 
zone of inhibition (26.66±0.33 mm) 
against Staphylococcus aureus, when 
grown on Starch Casein (SC) medium (Fig 
1). The other six media also supported the 
growth of the strain however the 
bioactivity was less compared with SC 
medium. Therefore, SC medium with or 
without carbon and nitrogen sources was 
used as the basal medium (control) for 
rest of the experiments. 
 
Effect of carbon and nitrogen source 
 All of the test carbon sources 
supported the growth of Amycolatopsis sp. 
ST-28 (Fig 2). Maximum growth and 
bioactive metabolite production were 




obtained in the basal medium 
supplemented with mannose as sole 
carbon source followed by basal medium 
with dextrose and glycerol (Fig 2). The 
result showed that mannose at a 
concentration of 1% (w/v) produced maxi- 
 
  
Fig 1: Effect of different culture media on growth 
and bioactive metabolite production by Amycolatopsis 
sp. ST-28. Vertical bars represent standard error (±SE). 
Means with different letters within an assay were 
significantly different (p value <0.05). 
 
 
Fig 2: Effect of different carbon sources on growth 
and bioactive metabolite production by Amycolatopsis 
sp. ST-28. Vertical bars represent standard error (±SE). 
Means with different letters within an assay were 
significantly different (p value <0.05). The control used here 
is basal media. 
  
mum cell mass (66.33±1.2 mg/50ml) and 
inhibition zone (27.33±1.45 mm) against 
S. aureus. Further optimization of manno- 
se concentration showed that mannose at 
a concentration of 1.5% (w/v) was 
optimum for growth and bioactive 
metabolite production (Fig 3).  
 
 
Fig 3: Effect of concentration of Mannose on bioactive 
metabolite production by Amycolatopsis sp. ST-28. Vertical 
bars represent standard error (±SE). 
 The nitrogen sources demonstrated 
significant effect on growth and 
metabolism of Amycolatopsis sp. ST-28. 
Only few nitrogen sources were able to 
support the growth and bioactive 
metabolite production by the strain (Fig 
4). Peptone as sole nitrogen source in the 
basal medium produced maximum 
mycelial growth (66.66±1.20 mg/50ml) 
and zone of inhibition (27.66±1.20 mm), 
followed by basal medium with beef 
extract and yeast extract. Some nitrogen 
sources such as NaNO3, KNO3, NH4NO3, 
NH4Cl and L-asparagine had inhibitory 
effect on bioactive metabolite production 
and growth of the strain. The optimum 
concentration for better growth and 
antimicrobial metabolite production was 
0.8 % (w/v) peptone (Fig 5). 
Effect of temperature and pH 
 The results showed that the most 
suitable temperature for growth and 
antimicrobial metabolite production of 
Amycolatopsis sp. ST-28 was in the range 
of 30–32±1ºC. Beyond this temperature, 




growth and metabolite production of the 
strain considerably decreased. Maximum 
mycelial yield (67.33±0.88 mg/50ml) and 
antimicrobial metabolite production 
(27.33±0.33 mm) were recorded at 
32±1ºC (Fig 6). Thus Amycolatopsis sp. 
ST-28 has very narrow range of 
temperature for its growth and 
antimicrobial activity. 
 
Fig 4: Effect of nitrogen sources on the growth and bioactive 
metabolite production by Amycolatopsis sp. ST-28. Vertical 
bars represent standard error (±SE). Means with different 
letters within an assay were significantly different (p-value 
<0.05).). The control used here is basal media. 
 
Fig 5: Effect of concentration of Peptone on bioactive 
metabolite production by Amycolatopsis sp.  ST-28. Vertical 
bars represent standard error (±SE) 
 With regards to pH, the experiment 
revealed that Amycolatopsis sp. ST-28 
grew when the initial pH of the medium 
was adjusted to pH 5 to 9, and the 
biosynthesis of antimicrobial metabolite 
and growth were maximal at pH 6.5 with 
27.00±0.00 mm and 65±0.88 mg/50ml 
respectively. The growth and antimicrobial 
metabolite production decreased beyond 
pH 6.5 (Fig 7). 
 
Fig 6: Effect of different temperature ranges on growth and 
bioactive metabolite production by Amycolatopsis sp. ST-28. 
Vertical bars represent standard error (±SE). Means with 
different letters within an assay were significantly different 
(p-value <0.05).). The control used here is basal media. 
 
Fig 7: Effect of different pH ranges on growth and bioactive 
metabolite production by Amycolatopsis sp. ST-28. Vertical 
bars represent standard error (±SE). Means with different 
letters within an assay were significantly different (p-value 
<0.05).). The control used here is basal media. 




Effect of incubation period, agitation 
speed and inoculum volume 
 The results showed that under 
good aeration, maximum growth and 
antimicrobial metabolite production were 
obtained. The optimum incubation time 
was 11 days under shaking condition. 
There was gradual decrease of 
antimicrobial activity and growth with 
further extension of incubation time (Fig 
8). Inoculum dose of 11% (v/v) 
concentration was most effective for 
maximum growth and yield of 
antimicrobial metabolite (Fig 9). Table 1 
shows the detailed description of 
optimized culture conditions and 
nutritional requirements for maximum 
production of antimicrobial compounds. 
                                                                                                         
Fig 8: Effect of shaking and stationary condition on the 
growth and bioactive metabolite production Amycolatopsis 
sp. ST-28.  Vertical bars represent standard error (±SE). 
Means with different letters within an assay were 
significantly different (p-value <0.05). The control used here 
is basal media 
                                            
Fig 9: Effect of different levels of inoculums on growth and 
bioactive  metabolite production by Amycolatopsis sp. ST-
28. Vertical bars represent standard error (±SE). Means with 
different letters within an assay were significantly different 
(p-value <0.05).). The control used here is basal media 
 
 
Table 1: Optimized cultural parameters for the growth and antimetabolite production by rare actinobacterial isolate 
Amycolatopsis sp. ST-28 
Parameters Optimum value Dry mycelial weight (mg/50ml) Zone of inhibition (mm) 
Carbon source Mannose 66.33±1.2 27.33±1.45 
Mannose concentration 1.5% - 27.33±0.33 
Nitrogen source Peptone 66.66±1.2 27.66±1.2 
Peptone concentration 0.8% - 27.66±0.88 
Temperature 32ºC 67.33±0.88 27.33±0.33 
pH 6.5 65.00±0.88 27.66 ±1.3 
Inoculum volume 11%v/v 67.66±0.88 27.00±0.57 
Incubation period 11 days 66.66±1.4 27.00±00 
Agitation 150 rpm 66.66±1.4 27.00±00 
 
  





 New drugs, especially antibiotics, 
are urgently needed to counter the threats 
of antibiotic resistant pathogens and to 
combat life threatening infectious diseases 
(34). The prevalence of methicillin-
resistant S. aureus in hospitals has 
increased from 3% in the early 1980’s to 
as high as 40% in recent times (35) and 
reports also suggest that coagulase 
negative S. aureus (CoNS) are becoming 
increasingly important in hospital settings 
where they cause serious infections (36). 
The focus, therefore, is on the rarer group 
of non-Streptomycetes actinobacteria, 
which are yet to be well exploited for their 
rich chemical diversity. These rare 
actinobacteria produce diverse and 
unique, unprecedented, sometimes very 
complicated compounds with excellent 
bioactive potency, and usually low toxicity 
(37, 38).    
 Attempts are also being made to 
study the secondary metabolism of these 
rare actinobacteria for their ability to 
produce bioactive metabolites such as 
antibiotics. Nutritional parameters and 
growth conditions exert strong influence in 
production of secondary metabolite by 
microbes (39). The medium constitution 
together with the metabolic capacity of 
the producing organisms greatly affects 
antibiotic biosynthesis (32). Therefore, 
this present investigation was conducted 
to determine the optimal cultural 
conditions such as nutritional, physical 
and chemical parameters for enhanced 
production of antimicrobial compounds by 
Amycolatopsis sp. ST-28.   
 The results of our study show that 
Amycolatopsis sp. ST-28, which is a rare 
actinobacterium, exhibited prominent 
antimicrobial activity against S. aureus. 
Previous reports have demonstrated 
antibiotic activity of Amycolatopsis 
balhimycina and Amycolatopsis orientalis 
against methicillin resistant S. aureus 
strains (15, 40). Therefore during the 
optimization experiment in our study, S. 
aureus was selected as the target 
organism for the antimicrobial assay. 
Amycolatopsis sp. ST-28 showed highest 
growth and antimicrobial metabolite 
production in Starch casein broth (SCB) as 
compared to the other tested media in our 
study. Similar findings were observed with 
Arthrobacter sp. SAA16 and Streptomyces 
afghaniensis VPTS3-1, when inoculated in 
different media, with SCB proving to be 
the best medium for growth and 
antimicrobial metabolite production in 
these studies (39, 41). This informed our 
selection of SCB as the basal medium 
(with or without C-sources) for the 
optimization studies.   
 Carbon sources are utilized by 
microorganisms for production of cell 
mass, primary and secondary metabolites 
and also for energy (42). Of the various 
carbon sources tested, basal medium 
supplemented with mannose at a 
concentration of 1.5% as sole carbon 
source supported the maximum growth as 
well antimicrobial metabolite production. 
Similar study on Streptomyces by Kreig 
and Holt reported that mannose was one 
of the most fermentable carbon sources 
by the actinobacteria for antibiotic 
production (43). However, further 
increase in the concentration of mannose 
did not increase the antimicrobial 
metabolite production in our study. This is 
probably because higher concentration of 
carbon tends to cause carbon repression 
which interferes with secondary 
metabolite formation (44). Similarly, other 
researchers have reported that 
Amycolatopsis mediterranei utilized 
glucose (1%) for rifamycin production 
however increase in concentration of 
glucose did not increase rifamycin 
production, which is attributable also to 
carbon catabolite repression (45).
 Nitrogen plays an important role in 
biosynthesis of secondary metabolites. 
Nitrogen sources are classified into two 
types; inorganic nitrogen source which are 
regarded as the fast metabolizable 
nitrogen sources, wherein long-time 
accumulation of product does not occur, 
and the organic nitrogen sources are 
sustainable sources that are beneficial for 
steady accumulation of product (46). In 
the present study, organic nitrogen 
sources showed relatively higher 




antimicrobial metabolite production and 
growth as compared to inorganic nitrogen 
sources. Peptone, an organic nitrogen 
source at a concentration of 0.8 % (w/v) 
in the basal medium was found optimum 
for the growth and antimicrobial 
metabolite production. The results agree 
with the earlier studies which suggest that 
low concentration of peptone (1%) greatly 
favored antimicrobial metabolite yield 
(32). The inorganic nitrogen sources such 
as ammonium nitrate and ammonium 
chloride supported growth to certain 
extent but did not allow production of 
antimicrobial metabolite. This might be 
due to presence of ammonium which 
inhibits the biosynthesis of antibiotics by 
decreasing the activities of enzymes 
involved in nitrogen metabolism (47). This 
is similar to the findings of the work done 
by Yu et al., (48).   
 Physiological factors such as pH 
and temperature have profound effects on 
the microbial growth and antimicrobial 
metabolite production. The results of our 
study indicated that growth and 
antimicrobial activity increased with 
gradual increase of pH from 5 to optimum 
pH of 6.5, and thereafter decrease in 
antimicrobial metabolite production and 
growth occurred. Actinobacteria have the 
ability to tolerate wide range of 
temperature. Temperature of 32±1ºC was 
found optimal for growth as well 
antimicrobial metabolite production in our 
study, thus, confirming the organism as a 
strict mesophile. Similar studies 
conducted by other researchers have also 
confirmed pH and temperature as critical 
factors for growth and metabolism of 
actinobacteria (25, 41, 45, 49).   
 The variations in inoculum dose 
were also observed to have significant 
influence on growth and bioactive 
metabolite production in our study, with 
11% (v/v) inoculum found optimum for 
antimicrobial metabolite production when 
tested in the range of 2 to 15 %. Other 
researchers have demonstrated inoculum 
volume effects on bioactive metabolite 
production, with lower levels of inoculum 
resulting in insufficient biomass leading to 
reduced product formation, while higher 
level of inoculum may produce too much 
biomass leading to poor product formation 
(26, 48, 50).    
 The influence of incubation period 
and agitation has also been studied, as 
this forms an integral part of optimization. 
Krishna et al., observed that a period of 
11 days and aeration of 50/250ml was 
optimum for the production of rifamycin 
by Amycolatopsis mediterranei (45) while 
Thakur et al., observed that Streptomyces 
sp. 201 required a maximum period of              
6 days under shaking conditions for 
optimum antibiotic yield and biomass 
production (25). In the present study, 
maximum incubation period required for 
optimum growth and antibiotic yield was 
11 days under shaking conditions, but 
under stationary condition, the growth 
and antimicrobial metabolite production 
were comparatively slower and the 
optimum production of antibiotics was on 
the day 17. Thus, agitation which provides 
proper oxygen transfer to the cells 
generally caused increase in growth of the 
organism. 
Conclusion:   
 Our study reveals that a rare 
actinobacteria strain, Amycolatopsis sp. 
ST-28 isolated from tea garden soil 
produced maximum growth and bioactive 
metabolite with a medium supplemented 
with 1.5% mannose as carbon source, 
peptone at a concentration of 0.8% as 
nitrogen source, and other process 
parameters such as media pH of 6.5, 
incubation temperature of 32±1 ºC, 
inoculum volume of 11% (v/v) and 
incubation period of 11 days under 
shaking condition. Therefore, crude 
extracts of Amycolatopsis sp. ST-28 has 
huge potential to be explored as 
antimicrobial agents for future 
development. Further characterization, 
purification and elucidation of the 
antimicrobial compounds present in the 
crude extracts are parts of an ongoing 
research. 
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